Jeudan A/S
CSE:JDAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jeudan A/S
CSE:JDAN
|
DK |
|
Cardinal Health Inc
NYSE:CAH
|
US |
|
S
|
Sonae - SGPS SA
ELI:SON
|
PT |
|
B
|
BW Ideol AS
OSE:BWIDL
|
NO |
|
Del Monte Pacific Ltd
SGX:D03
|
SG |
|
Balchem Corp
NASDAQ:BCPC
|
US |
|
Endurance Motive SA
MAD:END
|
ES |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JDAN's stock price target?
Not Available
JDAN doesn't have any price targets made by Wall Street professionals.
What is Jeudan A/S's Revenue forecast?
Projected CAGR
-3%
For the last 14 years the
compound annual growth rate for
Jeudan A/S's revenue is
3%.
The projected
CAGR
for the next 12 years is
-3%.
What is Jeudan A/S's Operating Income forecast?
Projected CAGR
0%
For the last 14 years the
compound annual growth rate for
Jeudan A/S's operating income is
4%.
The projected
CAGR
for the next 12 years is
0%.
What is Jeudan A/S's Net Income forecast?
Projected CAGR
-6%
The
compound annual growth rate
of Jeudan A/S's net income for the next 12 years is
-6%.
